8 Weeks of L-CIT Supplementation and LIRET on Vascular Function in Hypertensive Postmenopausal Women

Hypertension Clinical Trial

Official title:

8 Weeks of L-Citrulline Supplementation to Improve Low-intensity Resistance Exercise Training Vascular Adaptations in Postmenopausal Women With Hypertension

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05227781
• Other study ID #: IRB2018-463
• Status: Completed
• Phase: N/A
• Start date: May 24, 2018
• Est. completion date: January 10, 2022

Study information

• Verified date: January 2022
• Source: Texas Tech University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overall objective of this project is to bring forth evidence that L-Citrulline (L-CIT) supplementation and low intensity resistance exercise training (LIRET) alone and combined will improve vascular function and muscle fitness (mass, strength, and exercise performance) in postmenopausal women with hypertension. The investigators' central hypothesis is that adjuvant L-CIT supplementation may synergistically enhance vascular (arterial stiffness, BP, muscle oxygenation, blood flow) and muscular (strength, exercise performance) responses to LIRET in postmenopausal women with hypertension by improving endothelial vasodilatory function.

Description:

Individuals who are on medications will refrain from use the morning of all laboratory visits. Participants will be asked to bring medications with them, and will be allowed to ingest it after the vascular measurements have been obtained.

There will be a total of 7 laboratory visits. The 1st visit will be approximately 1 hr and 45 minutes. The 2nd and 3rd visit will be approximately 2 hrs. The 4th and 6th visit will total about 2 hrs and 15 minutes and finally, the 5th and 7th visit will total about 1hr and 15 minutes. This means the total participant time for laboratory visits will be approximately 12 hours. In addition to this, the second 4 weeks of the 8 week study period will involve coming to the Kinesiology and Sport Management building at Texas Tech University main campus 3 times per week to perform the low-intensity resistance training intervention. These visits should last no more than 30-45 minutes.

The first 3 visits will be separated by 48-72 hrs. Visits 3 and 4 will be separated by 4 weeks (first 4 weeks of LCIT or Placebo supplementation). Visits 4 and 5 will be separated by 48-72 hours. Visits 5 and 6 will again be separated by 4 weeks (Second 4 weeks of LCIT or Placebo supplementation with the addition of Low-intensity resistance exercise in both groups).

Approximately 12 hours total for each of the 7 laboratory visits, as well as 30-45 minutes 3 times per week during the last 4 weeks of the 8 week study.

Using a parallel placebo-controlled design, postmenopausal women with elevated blood pressure or hypertension will be randomized to receive L-CIT supplementation (10g/day) alone for 4 weeks, followed by 4 weeks of L-CIT supplementation in combination with low-intensity resistance training or placebo (maltodextrin) alone for 4 weeks, followed by 4 weeks of placebo in combination with low-intensity resistance training.

Differences between conditions (Citrulline vs Placebo) will be analyzed with independent samples t-test. Two-way ANOVA with repeated measures with Bonferroni adjustments will be used to analyze group (CIT vs. PL) by time (baseline, post-supplementation only, supplement + low-intensity resistance exercise training) interactions between the outcome variables. If group-by-time interactions are detected, post-hoc comparisons will be performed via paired or independent t-tests.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 29
• Est. completion date: January 10, 2022
• Est. primary completion date: January 10, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 50 Years to 75 Years

Eligibility

Inclusion Criteria:

• Women aged 50-75 years

• Resting systolic BP 120-159 mmHg

• Sedentary (< 60 min of exercise/week)

• Body mass index of 18.5-39.9 kg/m2)

• Fasting glucose < 126 mg/dL

• HbA1c < 6.4%.

Exclusion Criteria:

• Body mass index = 40 or < 18.5 kg/m2

• Diagnosed with type 1 or 2 diabetes mellitus

• Cardiovascular diseases

• Systolic blood pressure > 170 mmHg or on more than two anti-hypertensive medication

• Other chronic diseases such as cancer, asthma, glaucoma, thyroid, kidney, liver and pancreatic disease

• Individuals incorporated in a weight loss program and aerobic or resistance training program

• Heavy smokers (> 20 cigarettes per day)

• Heavy drinkers (> 12 alcoholic drinks per week)

Related Conditions & MeSH terms

• Hypertension
• Menopause

Intervention

Dietary Supplement:
• L-Citrulline
8 weeks of L-Citrulline supplementation (10 grams/day)
• Placebo
8 weeks of Placebo (maltodextrin; 10 grams/day)

Locations

Country	Name	City	State
United States	Texas Tech University	Lubbock	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Texas Tech University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in endothelial function via brachial artery flow-mediated dilation (effects of L-Citrulline only)	Endothelial function will be assessed at baseline and after 4 weeks of L-Citrulline supplementation alone using brachial artery flow-mediated dilation. All measurements will be performed using Doppler ultrasound.	4 weeks
Primary	Changes in endothelial function via superficial femoral artery flow-mediated dilation (effects of L-Citrulline only)	Endothelial function will be assessed at baseline and after 4 weeks of L-Citrulline supplementation alone using superficial femoral artery flow-mediated dilation. All measurements will be performed using Doppler ultrasound.	4 weeks
Primary	Changes in endothelial function via brachial artery flow-mediated dilation (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, endothelial function will be assessed after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs using brachial artery flow-mediated dilation. All measurements will be performed using Doppler ultrasound.	4 weeks
Primary	Changes in endothelial function via superficial femoral artery flow-mediated dilation (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, endothelial function will be assessed after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs using superficial femoral artery flow-mediated dilation. All measurements will be performed using Doppler ultrasound.	4 weeks
Primary	Changes in arm exercise blood flow (effects of L-Citrulline only)	Blood flow will be measured in the brachial artery during low intensity arm exercise. All measurements will be performed using Doppler ultrasound.	4 weeks
Primary	Changes in leg exercise blood flow (effects of L-Citrulline only)	Blood flow will be measured in the superficial femoral arteries during low intensity leg exercise. All measurements will be performed using Doppler ultrasound.	4 weeks
Primary	Changes in arm exercise blood flow (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, blood flow will be measured in the brachial artery during low intensity arm exercise. All measurements will be performed using Doppler ultrasound.	4 weeks
Primary	Changes in leg exercise blood flow (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, blood flow will be measured in the superficial femoral artery during low intensity leg exercise. All measurements will be performed using Doppler ultrasound.	4 weeks
Secondary	Changes in arterial stiffness via arm, leg, and aortic pulse wave velocity (effects of L-Citrulline only)	Arterial stiffness will be assessed using pulse wave velocity of the arm (carotid-radial), leg (femoral-ankle), and aorta (carotid-femoral) at baseline and after 4 weeks of L-Citrulline supplementation alone using applanation tonometry.	4 weeks
Secondary	Changes in arterial stiffness via arm, leg, and aortic pulse wave velocity (effects of L-Citrulline combined with low-intensity resistance exercise training)	Arterial stiffness will be assessed using pulse wave velocity of the arms (carotid-radial), legs (femoral-ankle), and aorta (carotid femoral) using applanation tonometry after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs.	4 weeks
Secondary	Changes in aortic hemodynamics using pulse wave analysis (effects of L-Citrulline only)	The speed and reflection pressures, both representing aortic hemodynamic parameters, will be assessed using radial artery pulses and a validated transfer function (AtCor Medical) at baseline and after 4 weeks of L-Citrulline supplementation alone.	4 weeks
Secondary	Changes in aortic hemodynamics using pulse wave analysis (effects of L-Citrulline combined with low-intensity resistance exercise training)	The speed and reflection pressures, both representing aortic hemodynamic parameters, will be assessed using radial artery pulses and a validated transfer function (AtCor Medical) after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs.	4 weeks
Secondary	Changes in brachial and aortic blood pressure via automated sphygmomanometry (effects of L-Citrulline only)	Brachial and aortic blood pressures (systolic and diastolic) will be assessed using an arm cuff at baseline and after 4 weeks of L-Citrulline supplementation alone.	4 weeks
Secondary	Changes in brachial and aortic blood pressure via automated sphygmomanometry (effects of L-Citrulline combined with low-intensity resistance exercise training)	Brachial and aortic blood pressures (systolic and diastolic) will be assessed using an arm cuff after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs.	4 weeks
Secondary	Changes in muscle strength (effects of L-Citrulline only)	Handgrip and leg strength (leg press, leg extension, leg flexion, calf raises) will be assessed at baseline and after 4 weeks of L-Citrulline supplementation alone.	4 weeks
Secondary	Changes in muscle strength (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, handgrip and leg strength (leg press, leg extension, leg flexion, calf raises) will be assessed after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs. These 4 exercises are to be of focus during the training sessions (3 days/week, 12 total training sessions).	4 weeks
Secondary	Quantification of L-Arginine (effects of L-Citrulline only)	Serum levels of L-Arginine (nmol/ul) will be assessed at baseline and after 4 weeks of L-Citrulline supplementation alone.	4 weeks
Secondary	Quantification of Arginase (effects of L-Citrulline only)	Serum levels ofarginase (pg/mL) will be assessed at baseline and after 4 weeks of L-Citrulline supplementation alone.	4 weeks
Secondary	Quantification of nitric oxide (effects of L-Citrulline only)	Serum levels ofnitric oxide (umol/L) will be assessed at baseline and after 4 weeks of L-Citrulline supplementation alone.	4 weeks
Secondary	Quantification of Endothelin-1 (effects of L-Citrulline only)	Serum levels of endothelin-1 (pg/mL) will be assessed at baseline and after 4 weeks of L-Citrulline supplementation alone.	4 weeks
Secondary	Quantification of L-Ornithine (effects of L-Citrulline only)	Serum levels of L-Ornithine (pmol/ul) will be assessed at baseline and after 4 weeks of L-Citrulline supplementation alone.	4 weeks
Secondary	Quantification of L-Arginine (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, serum levels of L-Arginine (nmol/ul) will be assessed after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs.	4 weeks
Secondary	Quantification of arginase (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, serum levels of arginase (pg/mL) will be assessed after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs.	4 weeks
Secondary	Quantification of nitric oxide (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, serum levels of nitric oxide (umol/L) will be assessed after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs.	4 weeks
Secondary	Quantification of endothelin-1 (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, serum levels of endothelin-1 (pg/mL) will be assessed after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs.	4 weeks
Secondary	Quantification of L-Ornithine (effects of L-Citrulline combined with low-intensity resistance exercise training)	After the 4-week assessment, serum levels of L-Ornithine (pmol/ul) will be assessed after 4 additional weeks of L-Citrulline supplementation with combined low-intensity resistance exercise training with the legs.	4 weeks